Amatuximab

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Amatuximab
Monoclonal antibody
Type Whole antibody
Source Chimeric (mouse/human)
Target mesothelin
Identifiers
CAS Number 931402-35-6 N
ATC code none
Chemical data
Formula C6394H9870N1694O2024S46
Molecular mass 144.33 kg/mol (peptide)
 NYesY (what is this?)  (verify)

Amatuximab is a chimeric monoclonal antibody designed for the treatment of cancer.[1]

Amatuximab was developed by Morphotek, Inc.

Amatuximab is also known as Anti-mesothelin monoclonal antibody MORAb-009. Amatuximab is an anti-mesothelin monoclonal antibody MORAb-009 binds to mesothelin (a protein that is made by some cancer cells) and stops the cells from dividing, and also called MORAb-009.[citation needed]

References

<templatestyles src="Reflist/styles.css" />

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

<templatestyles src="Asbox/styles.css"></templatestyles>

Stub icon

This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.

<templatestyles src="Asbox/styles.css"></templatestyles>

Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.
  1. ↑ Lua error in package.lua at line 80: module 'strict' not found.
Retrieved from "https://infogalactic.com/w/index.php?title=Amatuximab&oldid=707381648"